Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report

被引:46
作者
Lagier, J. -C. [1 ,2 ]
Delord, M. [2 ]
Million, M. [1 ,2 ]
Parola, P. [1 ,2 ]
Stein, A. [1 ,3 ]
Brouqui, P. [1 ,2 ]
Raoult, D. [1 ]
机构
[1] Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,INSERM 1095, F-13005 Marseille, France
[2] CHU Nord, Assistance Publ Hop Marseille, Serv Malad Infect & Trop, IHU Mediterranee Infect,Pole Malad Infect & Trop, F-13015 Marseille, France
[3] CHU Concept, Assistance Publ Hop Marseille, Serv Malad Infect & Trop, IHU Mediterranee Infect,Pole Malad Infect & Trop, F-13005 Marseille, France
关键词
MICROBIOTA TRANSPLANTATION; PRIME-TIME; INFECTION; OUTBREAK; DIARRHEA; DISEASE; READY;
D O I
10.1007/s10096-015-2394-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clostridium difficile ribotype 027 (CD027)-associated diarrhea preferentially affects elderly patients and causes a high mortality rate. Fecal microbiota transplantation has become an alternative treatment for recurrent C dflieile infections. An outbreak of CD027 infections has occurred in Marseille since March 2013, From March to November 2013, we treated patients using only antibiotics or fecal microbiota transplantation after at least three relapses. Beginning in November 2013, we performed early transplantation using a nasogastric tube during the first week of infection, in combination with antibiotic treatment. Sixty-one patients with a mean age of 84 years were hospitalized, including 42 patients treated only with antibiotics, three with tardive transplantation, and 16 with early transplantation. The patients were comparable in clinical involvement. The global mortality rate was 3/16 (18.75 A) among the patients treated by early transplantation and 29/45 (64.4 A) among the patients only treated by antibiotics or by tardive transplantation (p<0.01). Among these 45 patients, 23 (51 A) died at day 31, including 17 who died at day 7. Early fecal transplantation was associated with a significantly reduced mortality rate, with only one patient dead at day 31(6.25 %). In a Cox model, early transplantation was the only independent predictor of survival (hazard ratio 0.18, 95 % confidence interval 0.05-0.61, p=0.006). Six of the 16 patients (37.5 %) needed a second transplantation before symptom resolution. Early fecal microbiota transplantation in combination with antibiotics should be the first-line treatment for CD027 infections.
引用
收藏
页码:1597 / 1601
页数:5
相关论文
共 23 条
[11]   Clostridium difficile 027 Emerging Outbreak in Marseille, France [J].
Lagier, Jean-Christophe ;
Dubourg, Gregory ;
Cassir, Nadim ;
Fournier, Pierre-Edouard ;
Colson, Philippe ;
Richet, Herve ;
Brouqui, Philippe ;
Raoult, Didier .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (12) :1339-1341
[12]   A NEW SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS-II) BASED ON A EUROPEAN NORTH-AMERICAN MULTICENTER STUDY [J].
LEGALL, JR ;
LEMESHOW, S ;
SAULNIER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24) :2957-2963
[13]   Emergence of a Ribotype 244 Strain of Clostridium difficile Associated With Severe Disease and Related to the Epidemic Ribotype 027 Strain [J].
Lim, Sze K. ;
Stuart, Rhonda L. ;
Mackin, Kate E. ;
Carter, Glen P. ;
Kotsanas, Despina ;
Francis, Michelle J. ;
Easton, Marion ;
Dimovski, Karolina ;
Elliott, Briony ;
Riley, Thomas V. ;
Hogg, Geoff ;
Paul, Eldho ;
Korman, Tony M. ;
Seemann, Torsten ;
Stinear, Timothy P. ;
Lyras, Dena ;
Jenkin, Grant A. .
CLINICAL INFECTIOUS DISEASES, 2014, 58 (12) :1723-1733
[14]   A Mathematical Model to Evaluate the Routine Use of Fecal Microbiota Transplantation to Prevent Incident and Recurrent Clostridium difficile Infection [J].
Lofgren, Eric T. ;
Moehring, Rebekah W. ;
Anderson, Deverick J. ;
Weber, David J. ;
Fefferman, Nina H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (01) :18-27
[15]   A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality [J].
Loo, VG ;
Poirier, L ;
Miller, MA ;
Oughton, M ;
Libman, MD ;
Michaud, S ;
Bourgault, AM ;
Nguyen, T ;
Frenette, C ;
Kelly, M ;
Vibien, A ;
Brassard, P ;
Fenn, S ;
Dewar, K ;
Hudson, TJ ;
Horn, R ;
René, P ;
Monczak, Y ;
Dascal, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2442-2449
[16]   Fidaxomicin versus Vancomycin for Clostridium difficile Infection [J].
Louie, Thomas J. ;
Miller, Mark A. ;
Mullane, Kathleen M. ;
Weiss, Karl ;
Lentnek, Arnold ;
Golan, Yoav ;
Gorbach, Sherwood ;
Sears, Pamela ;
Shue, Youe-Kong .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05) :422-431
[17]   Impact of ribotype 027 on Clostridium difficile infection in a geriatric department [J].
Mascart, G. ;
Delmee, M. ;
Van Broeck, J. ;
Cytryn, E. ;
Karmali, R. ;
Cherifi, S. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (09) :1177-1182
[18]   Fecal Microbiota Transplantation: A Practical Update for the Infectious Disease Specialist [J].
Moore, Thomas ;
Rodriguez, Andres ;
Bakken, Johan S. .
CLINICAL INFECTIOUS DISEASES, 2014, 58 (04) :541-545
[19]   Fecal Microbiota Therapy: Ready for Prime Time? [J].
Rao, Krishna ;
Young, Vincent B. ;
Aronoff, David M. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (01) :28-30
[20]   Faecal transplantation and infectious diseases practitioners [J].
Raoult, D. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (11) :1097-1097